Výsledky vyhledávání

Efficacy of denbufylline in patients with multi-infarct dementia

Autor: W. H. Greb, M. O'Connolly, D. Dierdorf, M.‐E. R. Mayer, D. Wolf

Publikováno v: Drug Development Research. 14:195-198

The efficacy and tolerance of denbufylline (25 and 50 mg tid for three months) were investigated in 20 inpatients with cerebrovascular disease in a placebo-controlled, doubleblind parallel study. Denbufylline at 50 mg tid significantly improved the m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7d0aca1ea9e28a3a95697aa3b5c8160f
https://doi.org/10.1002/ddr.430140307

Zobrazit plný text záznamu

A review of the metabolism and pharmacokinetics of paroxetine in man

Autor: G. Mellows, P.F. Langley, W. H. Greb, R.E. Haddock, T.C.G. Tasker, C.M. Kaye, B. D. Zussman

Publikováno v: Acta Psychiatrica Scandinavica. 80:60-75

Paroxetine is well absorbed from the gastrointestinal tract, and appears to undergo first-pass metabolism which is partially saturable. Consistent with its lipophilic amine character, paroxetine is extensively distributed into tissues. Its plasma pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::942623ed566acde220d2a0a635455f9c
https://doi.org/10.1111/j.1600-0447.1989.tb07176.x

Zobrazit plný text záznamu

Absorption of paroxetine under various dietary conditions and following antacid intake

Autor: G. Buscher, D. Wolf, B. D. Zussman, M. A. Brett, H. W. Schrader, G. Mellows, H.‐D. Dierdorf, W. H. Greb

Publikováno v: Acta Psychiatrica Scandinavica. 80:99-101

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1163b35eafe88bb0376935a5b20b1d5
https://doi.org/10.1111/j.1600-0447.1989.tb07185.x

Zobrazit plný text záznamu

The pharmacokinetics of paroxetine in patients with liver cirrhosis

Autor: H.‐D. Dierdorf, A. Maleev, Z. Krastev, D. Wolf, K. M. Eckl, V. Vlahov, W. H. Greb, D. Terziivanov

Publikováno v: Acta psychiatrica Scandinavica. Supplementum. 350

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31f8cb8a108dcce521e1c93c95204fcb
https://pubmed.ncbi.nlm.nih.gov/2530799

Zobrazit plný text záznamu

[Absent enterohepatic circulation of the active metabolite of nabumetone]

Autor: M A, Brett, W H, Greb, H J, Kurth, G, Rülander, R E, Haddock, A R, Thawley

Publikováno v: Fortschritte der Medizin. 106(36)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7a4ca3e1c9b2e3a963fe1a8eb5e4d857
https://pubmed.ncbi.nlm.nih.gov/3069674

Zobrazit plný text záznamu

Endoscopic studies of nabumetone in patients with rheumatoid arthritis. A comparative endoscopic and histologic evaluation

Autor: W H, Greb, H W, von Schrader, S, Cerlek, M, Dominis, E, Hauptmann, N, Zenić

Publikováno v: The American journal of medicine. 83(4B)

Gastric tolerance to 1 g of nabumetone administered in a single nightly dose was assessed in two trials in patients with rheumatoid arthritis. Gastroscopy and histology of mucosal biopsy specimens were performed before and after the end of treatment

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::084f6b03fea0a743e1f2e380577d3cca
https://pubmed.ncbi.nlm.nih.gov/3318423

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání